For statin therapy for Veterans with cardiovascular disease and when limiting the analysis to only clinics that serve a high proportion of minority Veterans, there were no differences found between CRH-utilizing clinics and non-CRH-utilizing clinics (0.0% (–2.0, 2.0%), p=0.954). This evidence concerns the gene CRH and cardiovascular disorder.